Related Experiment Videos
Phenotypic clustering in MPZ mutations.
Michael E Shy1, Agnes Jáni, Karen Krajewski
1Department of Neurology, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine, Detroit, Michigan, USA. m.shy@wayne.edu
Brain : a Journal of Neurology
|January 9, 2004
Summary
Myelin protein zero (MPZ) mutations cause inherited neuropathies like CMT1B. Disruptions in MPZ structure lead to early-onset severe disease, while subtle changes cause later-onset neuropathy, impacting myelin compaction and cell interactions.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Myelin protein zero (MPZ) is crucial for myelin compaction and adhesion in the nervous system.
- Mutations in MPZ cause inherited demyelinating neuropathies, including Charcot-Marie-Tooth disease type 1B (CMT1B).
- Clinical presentations of MPZ-related neuropathies vary, ranging from early-onset severe forms to later-onset milder phenotypes.
Purpose of the Study:
- To correlate specific MPZ mutations with their resulting clinical phenotypes in patients.
- To understand the molecular mechanisms underlying the diverse presentations of MPZ-related neuropathies.
Main Methods:
- Genotypic analysis of 13 patients from 12 families with eight distinct MPZ mutations.
- Re-analysis of clinical data from 64 published CMT1B cases.
- Correlation of identified MPZ mutations with patient phenotypes.
Main Results:
- Most patients presented with either early-onset (prior to walking) or late-onset (around age 40) neuropathy, with 'classical' CMT phenotypes being less common.
- Mutations affecting the extracellular domain (charged amino acid addition, cysteine alteration) or cytoplasmic domain (truncation, conserved amino acid alteration) correlated with severe early-onset neuropathy.
- Subtle alterations in myelin structure due to specific mutations likely lead to late-onset neuropathy by disrupting Schwann cell-axonal interactions.
Conclusions:
- MPZ mutations significantly disrupting tertiary structure cause severe early-onset neuropathies by impairing myelin adhesion and compaction.
- More subtle MPZ alterations lead to late-onset neuropathies, likely through disrupted Schwann cell-axonal interactions.
- Genotype-phenotype correlations in MPZ mutations provide insights into the molecular basis of inherited demyelinating neuropathies.